FIGURE 2.
EGFR T790M mutation incidence among patients treated with EGFR‐TKIs. (a) First‐generation EGFR‐TKIs (gefitinib and erlotinib) versus afatinib. (b) First‐generation EGFR‐TKIs (gefitinib and erlotinib) vs. osimertinib
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.